Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy-based Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Viral Gene Delivery System
1.2.3 Non-viral Gene Delivery System
1.3 Market by Application
1.3.1 Global Gene Therapy-based Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy-based Drug Market Perspective (2018-2029)
2.2 Gene Therapy-based Drug Growth Trends by Region
2.2.1 Global Gene Therapy-based Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene Therapy-based Drug Historic Market Size by Region (2018-2024)
2.2.3 Gene Therapy-based Drug Forecasted Market Size by Region (2024-2029)
2.3 Gene Therapy-based Drug Market Dynamics
2.3.1 Gene Therapy-based Drug Industry Trends
2.3.2 Gene Therapy-based Drug Market Drivers
2.3.3 Gene Therapy-based Drug Market Challenges
2.3.4 Gene Therapy-based Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy-based Drug Players by Revenue
3.1.1 Global Top Gene Therapy-based Drug Players by Revenue (2018-2024)
3.1.2 Global Gene Therapy-based Drug Revenue Market Share by Players (2018-2024)
3.2 Global Gene Therapy-based Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy-based Drug Revenue
3.4 Global Gene Therapy-based Drug Market Concentration Ratio
3.4.1 Global Gene Therapy-based Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy-based Drug Revenue in 2022
3.5 Gene Therapy-based Drug Key Players Head office and Area Served
3.6 Key Players Gene Therapy-based Drug Product Solution and Service
3.7 Date of Enter into Gene Therapy-based Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy-based Drug Breakdown Data by Type
4.1 Global Gene Therapy-based Drug Historic Market Size by Type (2018-2024)
4.2 Global Gene Therapy-based Drug Forecasted Market Size by Type (2024-2029)
5 Gene Therapy-based Drug Breakdown Data by Application
5.1 Global Gene Therapy-based Drug Historic Market Size by Application (2018-2024)
5.2 Global Gene Therapy-based Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gene Therapy-based Drug Market Size (2018-2029)
6.2 North America Gene Therapy-based Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gene Therapy-based Drug Market Size by Country (2018-2024)
6.4 North America Gene Therapy-based Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapy-based Drug Market Size (2018-2029)
7.2 Europe Gene Therapy-based Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gene Therapy-based Drug Market Size by Country (2018-2024)
7.4 Europe Gene Therapy-based Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy-based Drug Market Size (2018-2029)
8.2 Asia-Pacific Gene Therapy-based Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gene Therapy-based Drug Market Size by Region (2018-2024)
8.4 Asia-Pacific Gene Therapy-based Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Therapy-based Drug Market Size (2018-2029)
9.2 Latin America Gene Therapy-based Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gene Therapy-based Drug Market Size by Country (2018-2024)
9.4 Latin America Gene Therapy-based Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy-based Drug Market Size (2018-2029)
10.2 Middle East & Africa Gene Therapy-based Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gene Therapy-based Drug Market Size by Country (2018-2024)
10.4 Middle East & Africa Gene Therapy-based Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Detail
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene Therapy-based Drug Introduction
11.1.4 Biogen Revenue in Gene Therapy-based Drug Business (2018-2024)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene Therapy-based Drug Introduction
11.2.4 Novartis Revenue in Gene Therapy-based Drug Business (2018-2024)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Detail
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene Therapy-based Drug Introduction
11.3.4 Gilead Sciences Revenue in Gene Therapy-based Drug Business (2018-2024)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Detail
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene Therapy-based Drug Introduction
11.4.4 Sarepta Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2024)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Detail
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Gene Therapy-based Drug Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Gene Therapy-based Drug Business (2018-2024)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Gene Therapy-based Drug Introduction
11.6.4 Amgen Revenue in Gene Therapy-based Drug Business (2018-2024)
11.6.5 Amgen Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Detail
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Gene Therapy-based Drug Introduction
11.7.4 Spark Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2024)
11.7.5 Spark Therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Detail
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Gene Therapy-based Drug Introduction
11.8.4 Akcea Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2024)
11.8.5 Akcea Therapeutics Recent Development
11.9 bluebird bio
11.9.1 bluebird bio Company Detail
11.9.2 bluebird bio Business Overview
11.9.3 bluebird bio Gene Therapy-based Drug Introduction
11.9.4 bluebird bio Revenue in Gene Therapy-based Drug Business (2018-2024)
11.9.5 bluebird bio Recent Development
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Detail
11.10.2 Sunway Biotech Business Overview
11.10.3 Sunway Biotech Gene Therapy-based Drug Introduction
11.10.4 Sunway Biotech Revenue in Gene Therapy-based Drug Business (2018-2024)
11.10.5 Sunway Biotech Recent Development
11.11 SIBIONO
11.11.1 SIBIONO Company Detail
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Gene Therapy-based Drug Introduction
11.11.4 SIBIONO Revenue in Gene Therapy-based Drug Business (2018-2024)
11.11.5 SIBIONO Recent Development
11.12 AnGes
11.12.1 AnGes Company Detail
11.12.2 AnGes Business Overview
11.12.3 AnGes Gene Therapy-based Drug Introduction
11.12.4 AnGes Revenue in Gene Therapy-based Drug Business (2018-2024)
11.12.5 AnGes Recent Development
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Detail
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Gene Therapy-based Drug Introduction
11.13.4 Orchard Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2024)
11.13.5 Orchard Therapeutics Recent Development
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Detail
11.14.2 Human Stem Cells Institute Business Overview
11.14.3 Human Stem Cells Institute Gene Therapy-based Drug Introduction
11.14.4 Human Stem Cells Institute Revenue in Gene Therapy-based Drug Business (2018-2024)
11.14.5 Human Stem Cells Institute Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gene Therapy-based Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Viral Gene Delivery System
Table 3. Key Players of Non-viral Gene Delivery System
Table 4. Global Gene Therapy-based Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Gene Therapy-based Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Gene Therapy-based Drug Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Gene Therapy-based Drug Market Share by Region (2018-2024)
Table 8. Global Gene Therapy-based Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Gene Therapy-based Drug Market Share by Region (2024-2029)
Table 10. Gene Therapy-based Drug Market Trends
Table 11. Gene Therapy-based Drug Market Drivers
Table 12. Gene Therapy-based Drug Market Challenges
Table 13. Gene Therapy-based Drug Market Restraints
Table 14. Global Gene Therapy-based Drug Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Gene Therapy-based Drug Market Share by Players (2018-2024)
Table 16. Global Top Gene Therapy-based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy-based Drug as of 2022)
Table 17. Ranking of Global Top Gene Therapy-based Drug Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Gene Therapy-based Drug Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gene Therapy-based Drug Product Solution and Service
Table 21. Date of Enter into Gene Therapy-based Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapy-based Drug Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Gene Therapy-based Drug Revenue Market Share by Type (2018-2024)
Table 25. Global Gene Therapy-based Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Gene Therapy-based Drug Revenue Market Share by Type (2024-2029)
Table 27. Global Gene Therapy-based Drug Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Gene Therapy-based Drug Revenue Market Share by Application (2018-2024)
Table 29. Global Gene Therapy-based Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Gene Therapy-based Drug Revenue Market Share by Application (2024-2029)
Table 31. North America Gene Therapy-based Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Gene Therapy-based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Gene Therapy-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Gene Therapy-based Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Gene Therapy-based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Gene Therapy-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Gene Therapy-based Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Gene Therapy-based Drug Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Gene Therapy-based Drug Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gene Therapy-based Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Gene Therapy-based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Gene Therapy-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Gene Therapy-based Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Gene Therapy-based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Gene Therapy-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. Biogen Company Detail
Table 47. Biogen Business Overview
Table 48. Biogen Gene Therapy-based Drug Product
Table 49. Biogen Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 50. Biogen Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Gene Therapy-based Drug Product
Table 54. Novartis Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Gilead Sciences Company Detail
Table 57. Gilead Sciences Business Overview
Table 58. Gilead Sciences Gene Therapy-based Drug Product
Table 59. Gilead Sciences Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 60. Gilead Sciences Recent Development
Table 61. Sarepta Therapeutics Company Detail
Table 62. Sarepta Therapeutics Business Overview
Table 63. Sarepta Therapeutics Gene Therapy-based Drug Product
Table 64. Sarepta Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 65. Sarepta Therapeutics Recent Development
Table 66. Alnylam Pharmaceuticals Company Detail
Table 67. Alnylam Pharmaceuticals Business Overview
Table 68. Alnylam Pharmaceuticals Gene Therapy-based Drug Product
Table 69. Alnylam Pharmaceuticals Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 70. Alnylam Pharmaceuticals Recent Development
Table 71. Amgen Company Detail
Table 72. Amgen Business Overview
Table 73. Amgen Gene Therapy-based Drug Product
Table 74. Amgen Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Spark Therapeutics Company Detail
Table 77. Spark Therapeutics Business Overview
Table 78. Spark Therapeutics Gene Therapy-based Drug Product
Table 79. Spark Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 80. Spark Therapeutics Recent Development
Table 81. Akcea Therapeutics Company Detail
Table 82. Akcea Therapeutics Business Overview
Table 83. Akcea Therapeutics Gene Therapy-based Drug Product
Table 84. Akcea Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 85. Akcea Therapeutics Recent Development
Table 86. bluebird bio Company Detail
Table 87. bluebird bio Business Overview
Table 88. bluebird bio Gene Therapy-based Drug Product
Table 89. bluebird bio Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 90. bluebird bio Recent Development
Table 91. Sunway Biotech Company Detail
Table 92. Sunway Biotech Business Overview
Table 93. Sunway Biotech Gene Therapy-based Drug Product
Table 94. Sunway Biotech Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 95. Sunway Biotech Recent Development
Table 96. SIBIONO Company Detail
Table 97. SIBIONO Business Overview
Table 98. SIBIONO Gene Therapy-based Drug Product
Table 99. SIBIONO Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 100. SIBIONO Recent Development
Table 101. AnGes Company Detail
Table 102. AnGes Business Overview
Table 103. AnGes Gene Therapy-based Drug Product
Table 104. AnGes Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 105. AnGes Recent Development
Table 106. Orchard Therapeutics Company Detail
Table 107. Orchard Therapeutics Business Overview
Table 108. Orchard Therapeutics Gene Therapy-based Drug Product
Table 109. Orchard Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 110. Orchard Therapeutics Recent Development
Table 111. Human Stem Cells Institute Company Detail
Table 112. Human Stem Cells Institute Business Overview
Table 113. Human Stem Cells Institute Gene Therapy-based Drug Product
Table 114. Human Stem Cells Institute Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 115. Human Stem Cells Institute Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy-based Drug Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Gene Therapy-based Drug Market Share by Type: 2022 VS 2029
Figure 3. Viral Gene Delivery System Features
Figure 4. Non-viral Gene Delivery System Features
Figure 5. Global Gene Therapy-based Drug Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 6. Global Gene Therapy-based Drug Market Share by Application: 2022 VS 2029
Figure 7. Neurological Diseases Case Studies
Figure 8. Cancer Case Studies
Figure 9. Other Case Studies
Figure 10. Gene Therapy-based Drug Report Years Considered
Figure 11. Global Gene Therapy-based Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Gene Therapy-based Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Gene Therapy-based Drug Market Share by Region: 2022 VS 2029
Figure 14. Global Gene Therapy-based Drug Market Share by Players in 2022
Figure 15. Global Top Gene Therapy-based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy-based Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Gene Therapy-based Drug Revenue in 2022
Figure 17. North America Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Gene Therapy-based Drug Market Share by Country (2018-2029)
Figure 19. United States Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Gene Therapy-based Drug Market Share by Country (2018-2029)
Figure 23. Germany Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Gene Therapy-based Drug Market Share by Region (2018-2029)
Figure 31. China Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Gene Therapy-based Drug Market Share by Country (2018-2029)
Figure 39. Mexico Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Gene Therapy-based Drug Market Share by Country (2018-2029)
Figure 43. Turkey Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Biogen Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 46. Novartis Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 47. Gilead Sciences Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 48. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 49. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 50. Amgen Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 51. Spark Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 52. Akcea Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 53. bluebird bio Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 54. Sunway Biotech Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 55. SIBIONO Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 56. AnGes Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 57. Orchard Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 58. Human Stem Cells Institute Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed